Free Trial

BioNTech's Omicron Presser Starts in Just Under 10 Minutes

CROSS ASSET
  • BioNTech update on the Omicron variant due to begin in 10 minutes.
  • Comes after press release this morning suggested that new strain can dodge two-dose regime of vaccine, but may still provide protection against severe disease.
  • Three doses of the Jab, however, seen as effective vs. Omicron.
  • Follow press conference live here: https://slidesync.com/n5kKz9qAxY

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.